Back
Cue Biopharma, Inc. 10K Form
Sell
7
CUE
Cue Biopharma, Inc.
Last Price:
$0.56
Seasonality Move:
10.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CUE News And Ratings
See the #1 stock for the next 7 days that we like better than CUE
CUE Financial Statistics
Sales & Book Value
| Annual Sales: | $9.3M |
|---|---|
| Cash Flow: | $-9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.17 |
| Price / Book: | 3.29 |
Profitability
| EPS (TTM): | -0.45560 |
|---|---|
| Net Income (TTM): | $-37.7M |
| Gross Margin: | $6.9M |
| Return on Equity: | -233.04% |
| Return on Assets: | -109.8% |
Cue Biopharma, Inc. Earnings Forecast
Key Cue Biopharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for CUE is 74.70%.
-
The Selling, General & Administrative Expenses for CUE have been equal to 157.05% of Gross Profit Margin.
-
The Research & Development expenses have been 386.84% of Revenue.
-
The Net Earning history of CUE is -437.97% of Total Revenues.
-
Per Share Earnings over the last 10 years have been positive in 5 years.
Cue Biopharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CUE |
| CUSIP: | 22978P |
| Website: | cuebiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0.47 |
|---|---|
| Current Ratio: | 1.66 |
| Quick Ratio: | 1.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CUE Technical Analysis vs Fundamental Analysis
Sell
7
Cue Biopharma, Inc. (CUE)
is a Sell
Is Cue Biopharma, Inc. a Buy or a Sell?
-
Cue Biopharma, Inc. stock is rated a SellThe current Cue Biopharma, Inc. [CUE] share price is $0.55. The Score for CUE is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.